Synergy china registry it was reported that the patient experienced coronary atherosclerotic heart disease.In (b)(6) 2020, the subject was referred for cardiac catheterization and index procedure was performed on the same day.The target lesion was located in the left main coronary artery (lmca) extending up to proximal left anterior descending (lad) artery with 90 % stenosis and was 18 mm long, with a reference vessel diameter of 3.8 mm.The target lesion was treated with pre-dilatation and placement of a 4.00 mm x 20 mm synergy stent system.Following post-dilatation, the residual stenosis was noted to be 0%.Six days later, subject was discharged on aspirin and ticagrelor.In (b)(6) 2023, the subject was diagnosed with coronary atherosclerotic heart disease and was hospitalized on the same day for further treatment.On the next day, the subject was referred for coronary angiography which revealed 100% stenosis noted in lmca extending up to proximal lad which had previously placed study device was treated with percutaneous coronary intervention.Post intervention, the residual stenosis was 0%.Target vessel revascularization was performed, and medication was given to treat the event.One week later, the event was considered to be recovered/resolved and on the same day the subject was discharged on aspirin and ticagrelor.
|